Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Taiwanese (TAIEX) Biotech Industry Analysis

UpdatedJan 24, 2025
DataAggregated Company Financials
Companies65
  • 7D-1.2%
  • 3M-0.7%
  • 1Y14.8%
  • YTD6.6%

Over the last 7 days, the Biotech industry has remained flat, although notably Lin BioScience gained 18%. The past year has been better, since the industry has gained 15% in that time. As for the next few years, earnings are expected to grow by 70% per annum.

Industry Valuation and Performance

Has the Taiwanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 24 Jan 2025NT$545.4bNT$24.8b-NT$10,902,841,000.0034.9x-50x22x
Sun, 22 Dec 2024NT$490.1bNT$24.8b-NT$10,848,531,000.0032.6x-45.2x19.8x
Tue, 19 Nov 2024NT$510.0bNT$24.9b-NT$10,463,953,000.0037.5x-48.7x20.5x
Thu, 17 Oct 2024NT$527.3bNT$23.5b-NT$10,829,095,000.0035.8x-48.7x22.5x
Sat, 14 Sep 2024NT$557.8bNT$23.5b-NT$10,829,095,000.0032.9x-51.5x23.8x
Mon, 12 Aug 2024NT$552.7bNT$22.1b-NT$11,296,958,000.0033.6x-48.9x25x
Wed, 10 Jul 2024NT$550.7bNT$21.9b-NT$11,110,643,000.0043.2x-49.6x25.1x
Fri, 07 Jun 2024NT$508.0bNT$21.9b-NT$11,110,643,000.0041.7x-45.7x23.2x
Sun, 05 May 2024NT$455.6bNT$21.6b-NT$12,502,137,000.0048.2x-36.4x21.1x
Tue, 02 Apr 2024NT$445.5bNT$20.9b-NT$10,667,106,000.0052.1x-41.8x21.3x
Thu, 29 Feb 2024NT$451.6bNT$20.7b-NT$9,591,454,000.0039.4x-47.1x21.8x
Sat, 27 Jan 2024NT$433.7bNT$19.9b-NT$9,830,596,000.0039.8x-44.1x21.8x
Mon, 25 Dec 2023NT$467.1bNT$19.9b-NT$9,737,975,000.0043.1x-48x23.5x
Wed, 22 Nov 2023NT$475.5bNT$19.4b-NT$10,027,536,000.0039x-47.4x24.5x
Fri, 20 Oct 2023NT$449.7bNT$18.4b-NT$10,823,013,000.0044.6x-41.6x24.4x
Sun, 17 Sep 2023NT$499.9bNT$18.3b-NT$10,776,417,000.0043x-46.4x27.3x
Tue, 15 Aug 2023NT$451.8bNT$18.9b-NT$10,207,311,000.0045x-44.3x23.9x
Thu, 13 Jul 2023NT$468.7bNT$18.7b-NT$10,725,166,000.0043.6x-43.7x25.1x
Sat, 10 Jun 2023NT$490.9bNT$17.6b-NT$11,251,141,000.0043.4x-43.6x27.9x
Mon, 08 May 2023NT$529.2bNT$18.5b-NT$9,923,392,000.0045.7x-53.3x28.6x
Wed, 05 Apr 2023NT$499.9bNT$20.3b-NT$9,157,006,000.0043.9x-54.6x24.6x
Fri, 03 Mar 2023NT$528.5bNT$22.3b-NT$7,093,875,000.0038x-74.5x23.7x
Sun, 29 Jan 2023NT$494.2bNT$21.8b-NT$7,778,690,000.0036.2x-63.5x22.7x
Tue, 27 Dec 2022NT$497.1bNT$21.8b-NT$7,778,690,000.0036.4x-63.9x22.8x
Thu, 24 Nov 2022NT$527.4bNT$21.8b-NT$7,522,211,000.0036.5x-70.1x24.2x
Sat, 22 Oct 2022NT$450.9bNT$23.1b-NT$6,633,590,000.0035.1x-68x19.5x
Mon, 19 Sep 2022NT$632.2bNT$23.1b-NT$6,633,590,000.0042.6x-95.3x27.4x
Wed, 17 Aug 2022NT$558.2bNT$23.6b-NT$5,600,931,000.0030.8x-99.7x23.7x
Fri, 15 Jul 2022NT$513.8bNT$22.5b-NT$5,642,821,000.0029.9x-91.1x22.8x
Sun, 12 Jun 2022NT$527.8bNT$22.5b-NT$5,642,821,000.0033.2x-93.5x23.4x
Tue, 10 May 2022NT$522.4bNT$21.7b-NT$5,726,051,000.0042.2x-91.2x24.1x
Thu, 07 Apr 2022NT$540.8bNT$21.5b-NT$5,761,086,000.0030.8x-93.9x25.2x
Sat, 05 Mar 2022NT$516.2bNT$18.0b-NT$5,619,404,000.0025x-91.9x28.7x
Mon, 31 Jan 2022NT$433.6bNT$17.9b-NT$5,532,702,000.0024.7x-78.4x24.2x
Price to Earnings Ratio

-78.4x


Total Market Cap: NT$433.6bTotal Earnings: -NT$5,532,702,000.00Total Revenue: NT$17.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Biotech Industry Price to Earnings3Y Average -60.7x202320242025
Current Industry PE
  • Investors are relatively neutral on the Taiwanese Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 23.9x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 11% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market2.11%
Healthcare-0.062%
Biotech-1.19%
Biotech-1.19%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6696 Lin BioScienceNT$152.0015.6%
+NT$1.6b		42.7%PB4.7x
6550 Polaris GroupNT$44.853.3%
+NT$1.1b		-36.6%PS442.4x
6541 Tanvex BioPharmaNT$69.005.7%
+NT$607.1m		6.3%PS276.4x
6547 Medigen Vaccine BiologicsNT$49.053.0%
+NT$476.7m		-20.1%PS24.9x
6875 Pharmosa BiopharmNT$56.206.2%
+NT$426.0m		-34.1%PS143.6x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6696

NT$152.00

Lin BioScience

7D

15.6%

1Y

42.7%

4147

NT$84.90

TaiMed Biologics

7D

-1.8%

1Y

-3.3%

6541

NT$69.00

Tanvex BioPharma

7D

5.7%

1Y

6.3%

6808

NT$59.50

3D Global Biotech

7D

-3.9%

1Y

205.9%

6446

NT$687.00

PharmaEssentia

7D

-4.7%

1Y

114.0%

6550

NT$44.85

Polaris Group

7D

3.3%

1Y

-36.6%

Does Polaris Group (TWSE:6550) Have A Healthy Balance Sheet?

Jan 13
Does Polaris Group (TWSE:6550) Have A Healthy Balance Sheet?

4142

NT$22.25

Adimmune

7D

-1.5%

1Y

-28.5%

There's No Escaping Adimmune Corporation's (TWSE:4142) Muted Revenues Despite A 26% Share Price Rise

Jan 13
There's No Escaping Adimmune Corporation's (TWSE:4142) Muted Revenues Despite A 26% Share Price Rise

6875

NT$56.20

Pharmosa Biopharm

7D

6.2%

1Y

-34.1%

6547

NT$49.05

Medigen Vaccine Biologics

7D

3.0%

1Y

-20.1%

6712

NT$178.50

Ever Supreme Bio Technology

7D

1.7%

1Y

0.2%

6748

NT$23.40

ACRO Biomedical

7D

-5.6%

1Y

-41.4%

4132

NT$16.55

Golden Biotechnology

7D

-5.7%

1Y

-53.4%

4726

NT$39.65

Mycenax Biotech

7D

-1.5%

1Y

1.3%

6617

NT$114.50

Gongwin Biopharm Holdings

7D

2.2%

1Y

-33.6%

1295

NT$81.00

Synbio Tech

7D

9.0%

1Y

5.7%

6827

NT$13.15

MegaPro Biomedical

7D

-9.0%

1Y

-38.3%